An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia
Abstract Introduction Identification of one’s status as a BRCA1/2 pathogenic variant carrier often marks the start of navigating challenging decisions related to cancer risk management and result disclosure. Carriers report unmet informational needs, but studies have yet to explore the specific aspe...
Main Authors: | Jeanette Yuen, Si Ming Fung, Chin Leong Sia, Mallika Venkatramani, Tarryn Shaw, Eliza Courtney, Shao-Tzu Li, Jianbang Chiang, Veronique Kiak-Mien Tan, Benita Kiat-Tee Tan, Joanne Ngeow |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13053-020-00154-x |
Similar Items
-
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
by: Zewen Zhang, et al.
Published: (2023-04-01) -
BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
by: Qianyan Li, et al.
Published: (2021-04-01) -
Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01) -
Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting
BRCA1/2
mutations in a Southeast Asian country
by: Chew, Winston, et al.
Published: (2019) -
Molecular Trajectory of BRCA1 and BRCA2 Mutations
by: Yuichiro Hatano, et al.
Published: (2020-03-01)